No active regulatory warnings
1 Identity
Hydrazine Sulfate
Hydrazine sulfate
BannedEvidence: ModerateRestrictedHydrazine sulfate was promoted by Joseph Gold (1970s) as a cancer 'cachexia cure' based on inhibition of gluconeogenesis via phosphoenolpyruvate carboxykinase [1]. Three NCI-sponsored RCTs found NO benefit and INCREASED TOXICITY (hepatotoxicity, neurotoxicity) vs placebo. Hydrazine is also a ROCKET FUEL component and a KNOWN CARCINOGEN (IARC Group 2B). Despite negative trials and carcinogenicity, hydrazine sulfate is still promoted in alternative cancer circles [1].
5
Hydrazine Sulfate
Hydrazine sulfate
BannedModerateRestricted
Clinical verdict: Hydrazine sulfate is a ROCKET FUEL COMPONENT and CARCINOGEN promoted as cancer treatment. Three NCI RCTs: NO benefit + INCREASED toxicity. IARC Group 2B carcinogen. Still promoted in alternative cancer networks despite definitive negative evidence. Patients taking rocket fuel for cancer based on debunked 1970s theory [1].
RDA
NOT a supplement — toxic industrial chemical
Target
N/A
UL
No safe dose
Category
Restricted
Population dosing
2 Risk self-assessment
DANGEROUS [1].
Select factors above to see your risk level
4 Lab interpreter
See overview
Your level:
Enter a value above
⚕ For healthcare professionals. Does not replace clinical judgment.
5 Quick facts
CategoryRestricted
Safety levelBanned
EvidenceModerate
RDANOT a supplement — toxic industrial chemical
Upper limit (UL)No safe dose
Scientific nameHydrazine sulfate
DANGEROUS/RESTRICTED — see overview[1]
6 Dosage by population
Adults Moderate
See product label
Elderly Moderate
See product label
Consider reduced renal/hepatic clearance. Start at lower end of range.
Athletes Limited
Standard dose
Obesity Limited
Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
Renal Limited
Consult specialist
Dose adjustment may be needed in renal impairment.
Vegan Moderate
Standard dose
DANGEROUS — NOT for supplementation. See overview [1].
7 Form comparison
| Form | Bioavailability | Vegan | Cost/day |
|---|---|---|---|
| ['See overview', 'restricted/banned', 'See overview [1].'] | Standard | Check label |
8 Clinical evidence
Strong evidence
See overview [1]. HIGH
Moderate evidence
See overview [1]. MODERATE
Insufficient evidence
See overview [1]. LOW
9 Safety
🚩 Red flags — when to stop and refer
● DANGEROUS — see overview [1]
Pregnancy
ABSOLUTELY CONTRAINDICATED — carcinogen + hepato/neurotoxin [1].
Pediatric
ABSOLUTELY NOT [1].
10 Toxicity and overdose
11 Drug interactions
12 Supplement interactions
13 Laboratory monitoring
14 Deficiency and prevalence
Risk factors
• DANGEROUS [1].
15 Frequently asked questions
DANGER ▼
Hydrazine sulfate is a ROCKET FUEL COMPONENT and CARCINOGEN promoted as cancer treatment. Three NCI RCTs: NO benefit + INCREASED toxicity. IARC Group 2B carcinogen. Still promoted in alternative cancer networks despite definitive negative evidence. Patients taking rocket fuel for cancer based on debunked 1970s theory [1].
16 Regulatory status
BANNED/RESTRICTED — see overview: [1].
17 References
[1]See overview. REVIEW
18 Related articles
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
Auto-updated from GMJ Newsroom. Articles tagged "Hydrazine Sulfate" appear here.
19 Cite this page
Vancouver
Pkhakadze G. Hydrazine Sulfate — safety profile [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/ingredients/hydrazine-sulfate/
APA 7th
Pkhakadze, G. (2026). Hydrazine Sulfate — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/hydrazine-sulfate/
CC BY 4.0
🛡 SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
GP
Reviewed by Prof. G. Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, PHIG
Last reviewed: May 2026 · Next: November 2026
This entry is provided for educational and public health purposes under CC BY 4.0. Consult your healthcare provider before starting any supplement. For corrections: info@accreditation.ge.
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD